{"name":"Oncopeptides","permalink":"oncopeptides","crunchbase_url":"http://www.crunchbase.com/company/oncopeptides","homepage_url":"http://www.oncopeptides.se","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":null,"number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"","phone_number":"46-(0)-705-695-471","description":"","created_at":"Sat Oct 22 06:50:47 UTC 2011","updated_at":"Sat Oct 22 06:55:54 UTC 2011","overview":"<p>Oncopeptides AB is a privately held company developing pharmaceuticals to treat cancer. The Company has developed proprietary technology based on creating pro-drugs with increased efficacy of already known and effective cytotoxic compounds. The lead substance, called J1 (melphalan flufenamide) is presently in a phase I/II clinical trial and is currently seeking co-development/licensing partners for the major geographical regions. Oncopeptides is a portfolio company of Karolinska Development AB publ and Stiftelsen Industrifonden.</p>","image":{"available_sizes":[[[150,34],"assets/images/resized/0015/9110/159110v1-max-150x150.jpg"],[[228,53],"assets/images/resized/0015/9110/159110v1-max-250x250.jpg"],[[228,53],"assets/images/resized/0015/9110/159110v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"CEO","person":{"first_name":"Jakob","last_name":"Lindberg","permalink":"jakob-lindberg","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$0","funding_rounds":[],"investments":[],"acquisition":null,"acquisitions":[],"offices":[],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}